KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Depreciation and Depletion (2023 - 2025)

Vir Biotechnology (VIR) has disclosed Depreciation and Depletion for 3 consecutive years, with $2.8 million as the latest value for Q4 2025.

  • Quarterly Depreciation and Depletion rose 3.7% to $2.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.4 million through Dec 2025, down 19.72% year-over-year, with the annual reading at $11.4 million for FY2025, 19.72% down from the prior year.
  • Depreciation and Depletion hit $2.8 million in Q4 2025 for Vir Biotechnology, down from $2.9 million in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $5.5 million in Q1 2023 to a low of $2.7 million in Q4 2024.
  • Historically, Depreciation and Depletion has averaged $3.7 million across 3 years, with a median of $3.6 million in 2024.
  • Biggest five-year swings in Depreciation and Depletion: tumbled 37.21% in 2024 and later grew 3.7% in 2025.
  • Year by year, Depreciation and Depletion stood at $4.3 million in 2023, then crashed by 37.21% to $2.7 million in 2024, then increased by 3.7% to $2.8 million in 2025.
  • Business Quant data shows Depreciation and Depletion for VIR at $2.8 million in Q4 2025, $2.9 million in Q3 2025, and $2.9 million in Q2 2025.